Admac Group

Delhi, India Founded: 2008 • Age: 18 yrs
Pharmaceutical formulations and oncology services are provided internationally with a focus on quality.

About Admac Group

Admac Group is a Healthcare company based in Delhi (India) founded in 2008. Pharmaceutical formulations and oncology services are provided internationally with a focus on quality. Admac Group offers products and services including Oncology Drugs and Formulations. Its focus areas include Pharmaceuticals, Oncology, Drug Formulations and Formulations. Its legal entity in India is CADMA BIOTECH LIMITED (U00304HR2005PLC035771).

Company details

Admac International is identified as a company that operates in the healthcare sector, where oncology and pharmaceutical formulations are emphasized. Global standards in quality are maintained through its processes, ensuring that products meet international benchmarks. The entity is involved in developing and distributing formulations for medical use, with a primary business model directed towards B2B interactions. While specific details on locations are limited, an international presence is implied, allowing operations to span various regions. Overall, adherence to quality protocols is noted in its oncology-focused endeavors.

Key Metrics
  • Net Loss
    -₹31,120

    FY 2023 · 0% margin

  • EBITDA
    -₹10,800

    FY 2023 · 0% margin

Products & Services of Admac Group

Admac Group offers a comprehensive portfolio of products and services, including Oncology Drugs and Formulations.

Oncology Drugs
Pharmaceutical Products

Oncology drugs are developed and formulated for medical use, with a focus on adhering to global quality standards.

Formulations
Drug Development

Various pharmaceutical formulations are created and supplied for healthcare applications, ensuring compliance with industry benchmarks.

Board of directors of Cadma Biotech Limited (Admac Group)

Cadma Biotech Limited is the primary company behind Admac Group. The board of Cadma Biotech Limited currently have 3 directors; the longest-serving is Nilesh Batra, appointed in 2019. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Nilesh Batra
DIN 07956257
Director24 Jan 20197 yrs 9 moCadma Biotech Limited
Sat Pal Malhotra
DIN 07956222
Director14 May 20215 yrs 5 moCadma Biotech Limited
Ramesh Chand Sharma
DIN 00263108
Director07 Jun 20215 yrs 4 moCadma Biotech Limited

Financials of Admac Group

Figures of Cadma Biotech Limited, the primary company behind Admac Group, for FY 2023. Net loss was -₹31,120 (0% margin). EBITDA was -₹10,800 (0% margin).

  • -₹31,120Net loss · 0% margin
  • -₹10,800EBITDA · 0% margin
  • ₹5 LakhPaid-up capital

Balance sheet, profit and loss, cash flow and ratios of Cadma Biotech Limited are on its company page.

Premium access

Detailed financial statements for Admac Group

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Admac Group

Admac Group was founded in 2008.

Admac Group is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.

Admac International is identified as a company that operates in the healthcare sector, where oncology and pharmaceutical formulations are emphasized. Global standards in quality are maintained through its processes, ensuring that products meet international benchmarks. The entity is involved in developing and distributing formulations for medical use, with a primary business model directed towards B2B interactions. While specific details on locations are limited, an international presence is implied, allowing operations to span various regions. Overall, adherence to quality protocols is noted in its oncology-focused endeavors.

Admac Group offers Oncology Drugs and Formulations.

Admac Group operates through Cadma Biotech Limited.

The legal entities of Admac Group currently have 3 directors, including Nilesh Batra, Ramesh Chand Sharma, Sat Pal Malhotra.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available